Peter G Kaufmann Selected Research

Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)

6/2003

Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter G Kaufmann Research Topics

Disease

4	Weight Loss (Weight Reduction) 11/2021 - 11/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 11/2018 - 07/2005
2	Infarction (Infarctions) 01/2017 - 06/2003
2	Hypertension (High Blood Pressure) 01/2017 - 07/2004
2	Myocardial Infarction 07/2005 - 07/2004
2	Coronary Disease (Coronary Heart Disease) 07/2005 - 07/2004
1	Type 2 Diabetes Mellitus (MODY) 06/2020
1	Acute Coronary Syndrome 01/2017
1	Mood Disorders (Mood Disorder) 08/2005

Drug/Important Bio-Agent (IBA)

3	4-nitro-3-dimethylaminopropiophenoneIBA 11/2021 - 01/2019
3	Antidepressive Agents (Antidepressants)IBA 07/2005 - 06/2003
2	Biological ProductsIBA 11/2018 - 08/2005
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	CholesterolIBA 01/2017
1	Sertraline (Zoloft)FDA LinkGeneric 07/2004
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 06/2003

Therapy/Procedure

1	Stents 01/2017